Abeona Therapeutics Inc Shares Approach 52-Week Low - Market Mover
The shares closed 1.1% above its 52-week low of $0.27, with trading volume lower than its 30 day average
Jan 15, 2022 by Kwhen Finance Editors
Abeona Therapeutics Inc (ABEO) shares closed today at 1.1% above its 52 week low of $0.27, giving the company a market cap of $27M. The stock is currently down 19.7% year-to-date, down 84.9% over the past 12 months, and down 94.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%.
Trading Activity
- Trading volume this week was 41.8% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
- The stock closed at 5.4% lower than its 5-day moving average, 13.2% lower than its 20-day moving average, and 64.6% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Abeona Therapeutics Inc | 0.9 | -19.7 | -84.9 | -92.1 | 11.1 |
| Dow Jones Industrial Average | -0.6 | -0.6 | 18.2 | -3.1 | 22.0 |
| S&P 500 Index | 0.0 | -2.2 | 23.9 | -3.9 | 26.9 |
| Health Care | -0.2 | -5.5 | 13.0 | -6.8 | 19.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -1581.4%
- The company's stock price performance over the past 12 months lags the peer average by 926.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc | ABEO | 0 | -19.7 | -84.9 | -92.1 | 11.1 |
| Peer Avg | N/A | 7.1 | 1.3 | -8.3 | -11.9 | 114.4 |
| Merck & Co Inc | MRK | 28.5 | 6.1 | 2.3 | -9.9 | 447.3 |
| Taro Pharmaceutical Industries | TARO | 0 | -0.8 | -35.4 | -37.9 | 10.4 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: